Linus D. Kloker

Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

B7-H3 membranous expression correlates with histological grading in a two-center cohort of 133 pre-treatment bone and soft tissue sarcoma samples.

B7-H3 membranous expression correlates with histological grading in a two-center cohort of 133 pre-treatment bone and soft tissue sarcoma samples.

Journal: BMC cancer

Published: February 26, 2026

Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734.

Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734.

Journal: Viruses

Published: January 15, 2026

When AI joins the table: evaluating large language model performance in soft tissue sarcoma tumor board decisions.

When AI joins the table: evaluating large language model performance in soft tissue sarcoma tumor board decisions.

Journal: Journal of cancer research and clinical oncology

Published: December 01, 2025

Moving Tumor-Agnostic Therapy to the Big Stage: Translational and Molecular Oncology Highlights from the ESMO Congress 2025.

Moving Tumor-Agnostic Therapy to the Big Stage: Translational and Molecular Oncology Highlights from the ESMO Congress 2025.

Journal: Oncology research and treatment

Published: December 01, 2025

An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samples.

An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samples.

Journal: Oncogene

Published: November 04, 2025

The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell lines.

The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell lines.

Journal: Molecular therapy. Oncology

Published: July 31, 2025

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.

Journal: Molecular therapy. Oncology

Published: March 09, 2025

NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT).

NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 11, 2025

Case report: Pulmonary Ewing sarcoma disguised as non-small cell lung cancer.

Case report: Pulmonary Ewing sarcoma disguised as non-small cell lung cancer.

Journal: Frontiers in oncology

Published: June 14, 2024

Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma.

Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma.

Journal: Cancers

Published: December 13, 2023

Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.

Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 24, 2023

NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP).

NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP).

Journal: Pediatric blood & cancer

Published: September 14, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026